{"id":1147,"date":"2025-11-27T14:17:16","date_gmt":"2025-11-27T06:17:16","guid":{"rendered":"http:\/\/192.168.6.218\/?p=1147"},"modified":"2026-08-24T08:14:29","modified_gmt":"2026-08-24T00:14:29","slug":"2025-11-27-en","status":"publish","type":"post","link":"https:\/\/www.trx.com.tw\/en\/2025-11-27-en\/","title":{"rendered":"The Investigational Oral Anti-Cancer Drug CVM-1118 Receives NMPA Approval to Initiate a Phase II Clinical Trial for Intermediate-Stage Liver Cancer in China."},"content":{"rendered":"<p class=\"wp-block-paragraph\">The anti-cancer drug, CVM-1118, has received approval from China\u2019s National Medical Products Administration (NMPA) to initiate a Phase II clinical trial in China under Protocol No. CVM-010.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Phase II trial will evaluate the safety and efficacy of CVM-1118 in combination with Tyvyt\u00ae (sintilimab injection), an immunotherapy product supplied by Innovent Biologics, Inc., and transarterial chemoembolization (TACE) in patients with unresectable intermediate-stage hepatocellular carcinoma (HCC) without extrahepatic metastasis.<\/p>","protected":false},"excerpt":{"rendered":"<p>The anti-cancer drug, CVM-1118, has received approval f [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"wp-custom-template-7","format":"standard","meta":{"footnotes":""},"categories":[25],"tags":[],"class_list":["post-1147","post","type-post","status-publish","format-standard","hentry","category-new-en"],"_links":{"self":[{"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/posts\/1147","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/comments?post=1147"}],"version-history":[{"count":0,"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/posts\/1147\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/media?parent=1147"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/categories?post=1147"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/tags?post=1147"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}